| __timestamp | Apellis Pharmaceuticals, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 79838000 |
| Thursday, January 1, 2015 | 13730311 | 121816000 |
| Friday, January 1, 2016 | 22978599 | 117633000 |
| Sunday, January 1, 2017 | 40303878 | 117456000 |
| Monday, January 1, 2018 | 105285576 | 171984000 |
| Tuesday, January 1, 2019 | 220968770 | 257452000 |
| Wednesday, January 1, 2020 | 299921000 | 477643000 |
| Friday, January 1, 2021 | 420869000 | 540684000 |
| Saturday, January 1, 2022 | 387236000 | 651496000 |
| Sunday, January 1, 2023 | 354387000 | 666563000 |
Igniting the spark of knowledge
In the dynamic world of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Apellis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. have demonstrated significant commitment to R&D, with their investments reflecting broader industry trends.
From 2014 to 2023, Apellis Pharmaceuticals increased its R&D spending by over 4,000%, peaking in 2021. This surge underscores their dedication to pioneering treatments, particularly in the field of complement immunotherapy.
PTC Therapeutics, known for its focus on rare genetic disorders, has consistently outpaced Apellis in R&D expenditure. By 2023, their investment had grown by approximately 730%, highlighting their strategic focus on expanding their therapeutic pipeline.
These trends not only reflect the companies' growth trajectories but also their unwavering commitment to advancing medical science.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
R&D Insights: How PTC Therapeutics, Inc. and Xencor, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.